Jazz Pharmaceuticals JAZZ Effect of cross-border tax laws
Effect of cross-border tax laws at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's effect of cross-border tax laws.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Jazz Pharmaceuticals's effect of cross-border tax laws?
- Jazz Pharmaceuticals (JAZZ) reported effect of cross-border tax laws of $7.45M in Q4 2025.
- What does effect of cross-border tax laws mean?
- The tax impact resulting from international operations and cross-border tax laws.
- How do you interpret effect of cross-border tax laws?
- A benefit suggests favorable international tax treatment, while an expense indicates higher tax costs abroad.
- How does effect of cross-border tax laws compare across companies?
- Common for multinational corporations with significant non-domestic revenue streams.